VTGN
USDVistagen Therapeutics Inc. Common Stock
$4.070-0.110 (-2.632%)
Prix en Temps Réel
Healthcare
Biotechnologie
États-Unis
Graphique des Prix
Loading Chart...
Métriques Clés
Métriques de Marché
Ouverture
$4.180
Haut
$4.296
Bas
$4.060
Volume
0.21M
Fondamentaux de l'Entreprise
Capitalisation Boursière
124.9M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.57M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Bas $1.9Actuel $4.070Haut $4.65
Actualités Connexes
BusinessWire
Vistagen to Report Fiscal Year 2026 Second Quarter Results and Host Corporate Update Conference Call on November 13, 2025
Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called
Voir plus
BusinessWire
Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder
Topline results for the trial are expected by year end Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a
Voir plus
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.